PURPOSE: To investigate pan-ethnic SMN1 copy-number and sequence variation by hybridization-based target enrichment coupled with massively parallel sequencing or next-generation sequencing (NGS). METHODS: NGS reads aligned to SMN1 and SMN2 exon 7 were quantified to determine the total combined copy number of SMN1 and SMN2. The ratio of SMN1 to SMN2 was calculated based on a single-nucleotide difference that distinguishes the two genes. SMN1 copy-number results were compared between the NGS and quantitative polymerase chain reaction and/or multiplex ligation-dependent probe amplification. The NGS data set was also queried for the g.27134T>G single-nucleotide polymorphism (SNP) and other SMN1 sequence pathogenic variants. RESULTS: The sensitivity of the test to detect spinal muscular atrophy (SMA) carriers with one copy of SMN1 was 100% (95% confidence interval (CI): 95.9-100%; n = 90) and specificity was 99.6% (95% CI: 99.4-99.7%; n = 6,648). Detection of the g.27134T>G SNP by NGS was 100% concordant with an restriction fragment-length polymorphism method (n = 493). Ten single-nucleotide variants in SMN1 were detectable by NGS and confirmed by gene-specific amplicon-based sequencing. This comprehensive approach yielded SMA carrier detection rates of 90.3-95.0% in five ethnic groups studied. CONCLUSION: We have developed a novel, comprehensive SMN1 copy-number and sequence variant analysis method by NGS that demonstrated improved SMA carrier detection rates across the entire population examined.Genet Med advance online publication 19 January 2017.
PURPOSE: To investigate pan-ethnic SMN1 copy-number and sequence variation by hybridization-based target enrichment coupled with massively parallel sequencing or next-generation sequencing (NGS). METHODS: NGS reads aligned to SMN1 and SMN2 exon 7 were quantified to determine the total combined copy number of SMN1 and SMN2. The ratio of SMN1 to SMN2 was calculated based on a single-nucleotide difference that distinguishes the two genes. SMN1 copy-number results were compared between the NGS and quantitative polymerase chain reaction and/or multiplex ligation-dependent probe amplification. The NGS data set was also queried for the g.27134T>G single-nucleotide polymorphism (SNP) and other SMN1 sequence pathogenic variants. RESULTS: The sensitivity of the test to detect spinal muscular atrophy (SMA) carriers with one copy of SMN1 was 100% (95% confidence interval (CI): 95.9-100%; n = 90) and specificity was 99.6% (95% CI: 99.4-99.7%; n = 6,648). Detection of the g.27134T>G SNP by NGS was 100% concordant with an restriction fragment-length polymorphism method (n = 493). Ten single-nucleotide variants in SMN1 were detectable by NGS and confirmed by gene-specific amplicon-based sequencing. This comprehensive approach yielded SMA carrier detection rates of 90.3-95.0% in five ethnic groups studied. CONCLUSION: We have developed a novel, comprehensive SMN1 copy-number and sequence variant analysis method by NGS that demonstrated improved SMA carrier detection rates across the entire population examined.Genet Med advance online publication 19 January 2017.
Authors: I Cuscó; M J Barceló; E del Rio; Y Martín; C Hernández-Chico; E Bussaglia; M Baiget; E F Tizzano Journal: Hum Genet Date: 2001-03 Impact factor: 4.132
Authors: P E McAndrew; D W Parsons; L R Simard; C Rochette; P N Ray; J R Mendell; T W Prior; A H Burghes Journal: Am J Hum Genet Date: 1997-06 Impact factor: 11.025
Authors: G van der Steege; P M Grootscholten; P van der Vlies; T G Draaijers; J Osinga; J M Cobben; H Scheffer; C H Buys Journal: Lancet Date: 1995-04-15 Impact factor: 79.321
Authors: Minjie Luo; Liu Liu; Inga Peter; Jun Zhu; Stuart A Scott; Geping Zhao; Chevonne Eversley; Ruth Kornreich; Robert J Desnick; Lisa Edelmann Journal: Genet Med Date: 2013-06-20 Impact factor: 8.822
Authors: Sumit Punj; Yassmine Akkari; Jennifer Huang; Fei Yang; Allison Creason; Christine Pak; Amiee Potter; Michael O Dorschner; Deborah A Nickerson; Peggy D Robertson; Gail P Jarvik; Laura M Amendola; Jennifer Schleit; Dana Kostiner Simpson; Alan F Rope; Jacob Reiss; Tia Kauffman; Marian J Gilmore; Patricia Himes; Benjamin Wilfond; Katrina A B Goddard; C Sue Richards Journal: Am J Hum Genet Date: 2018-05-10 Impact factor: 11.025
Authors: Mark J Cowley; Yu-Chi Liu; Karen L Oliver; Gemma Carvill; Candace T Myers; Velimir Gayevskiy; Martin Delatycki; Danique R M Vlaskamp; Ying Zhu; Heather Mefford; Michael F Buckley; Melanie Bahlo; Ingrid E Scheffer; Marcel E Dinger; Tony Roscioli Journal: Hum Mutat Date: 2019-01-31 Impact factor: 4.878
Authors: Julia C van Campen; Elizabeth S A Sollars; Rebecca C Thomas; Clare M Bartlett; Antonio Milano; Matthew D Parker; Jennifer Dawe; Peter R Winship; Gerrard Peck; Darren Grafham; Richard J Kirk; James R Bonham; Anne C Goodeve; Ann Dalton Journal: Int J Neonatal Screen Date: 2019-11-05
Authors: John N Milligan; Jessica L Larson; Stela Filipovic-Sadic; Walairat Laosinchai-Wolf; Ya-Wen Huang; Tsang-Ming Ko; Kristin M Abbott; Henny H Lemmink; Minna Toivonen; Johanna Schleutker; Caren Gentile; Vivianna M Van Deerlin; Huiping Zhu; Gary J Latham Journal: J Mol Diagn Date: 2021-03-30 Impact factor: 5.341
Authors: Mingjue Zhao; Mulias Lian; Felicia S H Cheah; Arnold S C Tan; Anupriya Agarwal; Samuel S Chong Journal: Front Genet Date: 2019-11-06 Impact factor: 4.599
Authors: Gidon Akler; Ashley H Birch; Nicole Schreiber-Agus; Xiaoqiang Cai; Guiqing Cai; Lisong Shi; Chunli Yu; Anastasia M Larmore; Geetu Mendiratta-Vij; Lama Elkhoury; Mitchell W Dillon; Jun Zhu; Andrew S Mclellan; Funda E Suer; Bryn D Webb; Eric E Schadt; Ruth Kornreich; Lisa Edelmann Journal: Mol Genet Genomic Med Date: 2019-12-27 Impact factor: 2.183